ESSILOR INTL S/S (OTCMKTS:ESLOY) Stock Rating Upgraded by Zacks Investment Research

Share on StockTwits

ESSILOR INTL S/S (OTCMKTS:ESLOY) was upgraded by Zacks Investment Research from a “hold” rating to a “buy” rating in a research note issued to investors on Wednesday, Zacks.com reports. The brokerage currently has a $86.00 price target on the stock. Zacks Investment Research‘s price objective points to a potential upside of 11.44% from the stock’s current price.

According to Zacks, “EssilorLuxottica Société is involved in the design, manufacture and distribution of ophthalmic lenses, frames and sunglasses. The company’s brand portfolio consists of Ray-Ban, Oakley, Varilux(R), Transitions(R), Sunglass Hut and LensCrafters. EssilorLuxottica Société, formerly known as Essilor International Société Anonyme, is based in Paris, France. “

Separately, Morgan Stanley upgraded ESSILOR INTL S/S from an “equal weight” rating to an “overweight” rating in a report on Monday, September 23rd.

ESLOY stock traded up $0.11 during midday trading on Wednesday, hitting $77.17. The stock had a trading volume of 34,268 shares, compared to its average volume of 57,139. The firm has a market cap of $33.66 billion, a price-to-earnings ratio of 18.20, a price-to-earnings-growth ratio of 3.79 and a beta of 0.60. The business has a 50-day moving average of $75.99 and a two-hundred day moving average of $70.00. ESSILOR INTL S/S has a 52-week low of $53.76 and a 52-week high of $77.82.

About ESSILOR INTL S/S

EssilorLuxottica Société anonyme designs, manufactures, and distributes ophthalmic lenses, frames, and sunglasses North America, Europe, Asia, Oceania, Africa, Latin America, and internationally. It operates in five segments: Wholesale, Retail, Lenses and Optical Instruments, Equipment, and Sunglasses & Readers.

Read More: Dividend Stocks – Are They Right For You?

Get a free copy of the Zacks research report on ESSILOR INTL S/S (ESLOY)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for ESSILOR INTL S/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ESSILOR INTL S/S and related companies with MarketBeat.com's FREE daily email newsletter.

 


Latest News

Yu Darvish Receives Cortisone Shot for Elbow Impingement
Yu Darvish Receives Cortisone Shot for Elbow Impingement
Red Sox and Brandon Phillips Agree to Minor League Deal
Red Sox and Brandon Phillips Agree to Minor League Deal
Chris Sale Proves He is 2018 AL Cy Young Candidate
Chris Sale Proves He is 2018 AL Cy Young Candidate
Strong Results by Clint Frazier Could Keep Him with Yankees
Strong Results by Clint Frazier Could Keep Him with Yankees
Giants Closer Breaks Hand Punching Door Following Poor Outing
Giants Closer Breaks Hand Punching Door Following Poor Outing
Evan Longoria Out Six to Eight Weeks With Broken Hand
Evan Longoria Out Six to Eight Weeks With Broken Hand


 
© 2006-2020 BBNS.